ProShare Advisors
BNGO icon

ProShare Advisors’s Bionano Genomics BNGO Stock Holding History

ProShare Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-59
Closed -$39.1K – 1855
2023
Q1 		$39.1K Sell
59
-5
-8% -$4.44K ﹤0.01% 1693
2022
Q4 		$56.2K Buy
64
+10
+19% +$12.6K ﹤0.01% 1726
2022
Q3 		$59K Sell
54
-1
-2% -$1.32K ﹤0.01% 1643
2022
Q2 		$45K Sell
55
-36
-40% -$37K ﹤0.01% 1713
2022
Q1 		$141K Sell
91
-15
-14% -$20.2K ﹤0.01% 1968
2021
Q4 		$191K Buy
106
+46
+77% +$123K ﹤0.01% 2048
2021
Q3 		$198K Sell
60
-62
-51% -$217K ﹤0.01% 1798
2021
Q2 		$535K Buy
+122
New +$482K ﹤0.01% 1486

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ProShare Advisors's BNGO Position: Q2 2023 in Review

ProShare Advisors sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 59 shares — an estimated $39.1K sold.

ProShare Advisors first reported a position in BNGO in Q2 2021 and held it in 8 quarters. The position peaked at $535K in Q2 2021. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

  • ProShare Advisors reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
  • ProShare Advisors sold 59 Bionano Genomics shares in Q2 2023, an estimated $39.1K.
  • ProShare Advisors first reported a position in Bionano Genomics in Q2 2021 and held it in 8 quarters.
  • ProShare Advisors's Bionano Genomics position peaked at $535K in Q2 2021.
  • 108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on ProShare Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.